LOSI, Lorena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.760
EU - Europa 14.885
AS - Asia 9.256
SA - Sud America 1.224
Continente sconosciuto - Info sul continente non disponibili 246
AF - Africa 171
OC - Oceania 16
Totale 48.558
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.399
IT - Italia 7.378
GB - Regno Unito 3.251
SG - Singapore 3.196
CN - Cina 2.300
HK - Hong Kong 1.035
BR - Brasile 907
VN - Vietnam 894
SE - Svezia 840
DE - Germania 754
BD - Bangladesh 481
FR - Francia 421
FI - Finlandia 412
UA - Ucraina 371
RU - Federazione Russa 368
NL - Olanda 334
TR - Turchia 278
KR - Corea 203
IN - India 201
CA - Canada 167
BG - Bulgaria 155
ID - Indonesia 139
AR - Argentina 118
MX - Messico 96
AL - Albania 82
PL - Polonia 79
ES - Italia 75
IQ - Iraq 73
JP - Giappone 70
AE - Emirati Arabi Uniti 68
ZA - Sudafrica 56
BE - Belgio 49
PK - Pakistan 49
IE - Irlanda 47
RO - Romania 44
LT - Lituania 43
CL - Cile 39
MY - Malesia 39
EC - Ecuador 36
CO - Colombia 33
CH - Svizzera 32
UZ - Uzbekistan 30
PH - Filippine 25
VE - Venezuela 24
MA - Marocco 22
CZ - Repubblica Ceca 20
NP - Nepal 20
PY - Paraguay 20
IL - Israele 18
KE - Kenya 18
JO - Giordania 17
LV - Lettonia 17
UY - Uruguay 17
SA - Arabia Saudita 16
AT - Austria 15
PE - Perù 15
CR - Costa Rica 14
EG - Egitto 14
TH - Thailandia 14
BO - Bolivia 13
DK - Danimarca 13
PT - Portogallo 13
TN - Tunisia 13
AU - Australia 12
DZ - Algeria 12
JM - Giamaica 12
BY - Bielorussia 11
ET - Etiopia 11
IR - Iran 11
KZ - Kazakistan 11
TW - Taiwan 11
AZ - Azerbaigian 10
GR - Grecia 10
GT - Guatemala 10
PR - Porto Rico 9
PS - Palestinian Territory 8
DO - Repubblica Dominicana 7
HU - Ungheria 7
KG - Kirghizistan 7
MD - Moldavia 7
NO - Norvegia 7
PA - Panama 7
SI - Slovenia 7
SV - El Salvador 7
HN - Honduras 6
NI - Nicaragua 6
RS - Serbia 6
BZ - Belize 5
QA - Qatar 5
BS - Bahamas 4
LK - Sri Lanka 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CG - Congo 3
EE - Estonia 3
EU - Europa 3
GA - Gabon 3
Totale 48.259
Salva come PNG Salva come JPEG
Città #
Southend 2.496
Singapore 2.044
Ashburn 1.880
Santa Clara 1.789
Fairfield 1.665
Woodbridge 1.130
Hong Kong 1.017
Chicago 1.009
Chandler 940
San Jose 851
Houston 832
Jacksonville 685
Los Angeles 685
Seattle 668
Wilmington 652
Rome 638
Hefei 601
Cambridge 592
Dearborn 574
Ann Arbor 532
Council Bluffs 506
Milan 498
Nyköping 485
Salt Lake City 441
Beijing 440
London 371
Modena 343
New York 315
Ho Chi Minh City 274
Helsinki 261
Elk Grove Village 215
Tampa 211
Hanoi 208
Naples 208
The Dalles 198
Seoul 192
San Diego 175
Dallas 166
Shanghai 163
Bologna 158
Princeton 157
Izmir 145
Sofia 140
Frankfurt am Main 135
Eugene 130
Sterling 125
Lauterbourg 122
Buffalo 120
Turin 119
Bari 114
Lancaster 114
São Paulo 103
Moscow 102
Florence 99
Boardman 91
Jakarta 91
Columbus 87
Palermo 86
Munich 83
Bremen 77
Cagliari 70
Parma 69
Tirana 67
Miami 66
Verona 66
Detroit 65
Reggio Emilia 65
Des Moines 64
Orem 63
Phoenix 63
Dulles 60
Tokyo 60
Catania 58
Perugia 58
Atlanta 57
Warsaw 56
Da Nang 53
Toronto 52
Redwood City 51
Fremont 47
Denver 46
Dublin 44
Pescara 43
Padova 41
Genoa 40
Chennai 39
Montreal 39
Brooklyn 37
Brussels 37
Stockholm 35
Kansas City 34
Trieste 34
Brescia 33
Falls Church 33
Haiphong 33
Pittsburgh 33
Rio de Janeiro 33
Guangzhou 32
Nanjing 29
Napoli 28
Totale 31.281
Salva come PNG Salva come JPEG
Nome #
Robbins e Cotran Atlante di Anatomia Patologica 6.630
Exome sequencing and bioinformatic approaches reveals rare sequence variants involved in cell signalling and elastic fibre homeostasis: new evidence in the development of ectopic calcification 531
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 462
LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells 460
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 457
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 451
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 439
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 429
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 425
Brooke-Spiegler syndrome: Report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes 422
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 420
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. 413
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 413
DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM) 411
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 410
Assessment of K-ras, Smad4 and p53 gene alterations in colorectal metastases and their role in the metastatic process 405
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 404
Repurposing of drugs targeting yap-tead functions 401
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 400
K-ras and p53 mutations in human colorectal aberrant crypt foci 396
Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions RID B-2583-2012 393
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 393
Microsatellite instability in multiple colorectal tumors 392
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 387
Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis 386
Aetiology of colorectal cancer and relevance of monogenic inheritance. 385
Preoperative Therapy for Lower Rectal Cancer and Modifications in Distance From Anal Sphincter 384
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 377
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 374
Aberrant crypt foci in patients with colorectal cancer 373
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 373
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 371
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 370
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 369
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 365
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 364
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 364
Promoter Methylation and Down-regulated Expression of the TBX15 Gene in Ovarian Carcinoma 356
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines 356
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 356
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool 351
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 351
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 349
Prognostic significance of K-ras mutations in colorectal carcinoma. 347
Histology of aberrant crypt foci in the human colon 343
Loss of Smad4 expression predicts liver metastasis in human colorectal cancer 342
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 339
Expression of p53 protein in prostate cancers of different histologic types. 339
Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers 339
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 338
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 331
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer 329
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 328
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 328
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 326
Primary mucinous (so-called colloid) carcinomas of the lung - A clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression 324
Stability of K-ras mutations throughout the natural history of human colorectal cancer. 319
Deep learning techniques for detecting preneoplastic and neoplastic lesions in human colorectal histological images 319
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting 315
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 314
Microsatellite instability and colorectal cancer prognosis. 313
MELANOSIS (PIGMENTED MELANOCYTOSIS) OF THE PROSTATE GLAND. 313
Loss of expression of μ-protocadherin and protocadherin-24 in sporadic and hereditary nonpolyposis colorectal cancers 312
Paneth and argyrophil cells in prostatic carcinoma. 305
Can immunohistochemistry improve the pathological diagnosis of placenta accreta spectrum (PAS) disorders? 304
Desmoplastic melanoma: a challenge for the oncologist 304
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 304
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 299
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 298
Evolution of intratumoral genetic heterogeneity during colorectal cancer progression 297
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells 296
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 295
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer 295
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 287
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 284
Prognostic value of "Dworak" tumor regression grade (TRG) after pre-operative chemo-radiotherapy in rectal cancer (RC) 281
Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals 281
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 280
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 280
Colorectal carcinoma in different age groups: A population based investigation 278
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 276
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 274
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 273
Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases 269
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 267
Biological characterization of mucinous carcinoma of the colon and rectum 264
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 261
CDX-2 homeobox gene and MUC2 expression identifies true mucinous (so-called colloid) carcinoma of the lung and justifies its indolent outcome 259
High Expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells 259
TERT promoter methylation and protein expression as predictive biomarkers for recurrence risk in patients with serous borderline ovarian tumours 249
Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. 248
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 247
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 246
Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells 241
Survival for colon and rectal cancer in a population-based cancer registry 241
Myxoid metastases of melanoma: report of three cases and review of the literature 239
Cadherins down-regulation: towards a better understanding of their relevance in colorectal cancer 239
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 237
Pigment epithelial-derived factor: a new player in dermal elastic fibre calcification? 237
Dermal Alterations in Clinically Unaffected Skin of Pseudoxanthoma elasticum Patients 235
Totale 39.905
Salva come PNG Salva come JPEG
Categoria #
all - tutte 180.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 180.963
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.224 0 361 305 241 124 176 224 201 359 225 649 359
2022/20233.584 377 366 236 330 371 456 148 356 401 119 215 209
2023/20243.619 187 202 247 363 571 310 287 376 152 288 262 374
2024/20258.195 314 144 308 676 1.443 1.094 640 541 969 413 725 928
2025/202616.161 813 550 917 2.524 4.435 907 1.425 607 1.269 1.120 896 698
2026/2027999 324 675 0 0 0 0 0 0 0 0 0 0
Totale 48.558